Adolor appoints Stephen W. Webster as CFO

Biopharmaceutical company Adolor Corp. said Friday it appointed Stephen W. Webster as chief financial officer, effective on or about June 30.

Webster succeeds Thomas Hess, who has resigned to pursue another business opportunity.

In his last post, Webster was managing director of the Investment Banking Division Healthcare Group at Broadpoint Capital.

Adolor shares rose 18 cents, or 3.5 percent, to $5.31. The stock, which has traded between $3.05 and $6.09 over the past 52 weeks, is up nearly 12 percent year-to-date.